1. |
From the Editor |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 2-2
&NA;,
Preview
|
PDF (845KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
2. |
A little wind does a lot of good |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 3-3
&NA;,
Preview
|
PDF (723KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
3. |
4Sthe first study to show that cholesterol reduction saves lives |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 4-6
Gill Higgins,
Preview
|
PDF (2458KB)
|
|
摘要:
For the first time, the ability of simvastatin to ‘save lives’ has been shown in a large, placebo-controlled trial involving patients with coronary artery disease. This is good news for Merck, as the results are likely to give physicians renewed confidence in prescribing simvastatin to patients with this condition. Although simvastatin stole the show at the 67th Scientific Sessions of the American Heart Association [Dallas, US; November 1994], ground-breaking results were also presented for pravastatin. The Kuopio Atherosclerosis Prevention Study (KAPS) showed that this drug is effective in the primary prevention setting. Compared with placebo, pravastatin significantly reduced the risk of atherosclerosis in individuals with mild to moderate hypercholesterolaemia who had no cardiac disease.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
4. |
Views in the news |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 6-6
&NA;,
Preview
|
PDF (820KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
5. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 7-7
&NA;,
Preview
|
PDF (725KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
6. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 8-8
&NA;,
Preview
|
PDF (747KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
7. |
Trial results from new topical drugs in dermatoses |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 9-10
Rodger W Hall,
Preview
|
PDF (1565KB)
|
|
摘要:
New agents set to make an impact in the field of dermatology include tazarotene for acne and psoriasis, and a combination of diclofenac with hyaluronic acid for actinic keratoses. Details of these approaches to treatment were presented at the 10th Annual Dermatology Update conference [Vancouver, Canada; October, 1994]. In addition, the risks and benefits of topical azelaic acid therapy for acne were discussed, as this agent is expected to be launched soon in the US and Canada.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
8. |
Antiatherosclerotic effects of HMG CoA reductase inhibitors |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 10-10
&NA;,
Preview
|
PDF (801KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 11-11
&NA;,
Preview
|
PDF (747KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
10. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 965,
1994,
Page 12-12
&NA;,
Preview
|
PDF (778KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|